Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Recruiting
Observational Study
Cardiovascular Diseases
Metabolic Syndrome
Obesity
Prediabetes
Mental Health Disorders
Endocrine Dysfunction
Type 2 Diabetes Mellitus (T2DM)
Chronic Kidney Disease (CKD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 7,000 (estimated)
- Sponsor
- Clindove Research LLC · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Any participant of age 18 years and over
* Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures.
Exclusion Criteria:
* Pregnant or breastfeeding individuals
* Individuals having severe cognitive impairment or…
Contacts